# The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients

> **NCT00497939** · NA · UNKNOWN · sponsor: **Hospital Authority, Hong Kong** · enrollment: 40 (estimated)

## Conditions studied

- Prostatic Hyperplasia
- Adrenergic Alpha-Antagonists

## Interventions

- **DRUG:** Saw palmetto and sanmiaoshan capsule

## Key facts

- **NCT ID:** NCT00497939
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2008-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2010-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00497939

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00497939, "The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT00497939. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*